Cargando…
Fibroblast growth factor receptor 1 gene amplification is associated with poor survival in patients with resected esophageal squamous cell carcinoma
To investigate the frequency and the prognostic impact of fibroblast growth factor receptor 1 (FGFR1) gene amplification in 526 curatively resected esophageal squamous cell carcinoma (ESCC). Using fluorescent in situ hybridization, high amplification was defined by an FGFR1/centromer 8 ratio is ≥ 2....
Autores principales: | Kim, Hyo Song, Lee, Seung Eun, Bae, Yoon Sung, Kim, Dae Joon, Lee, Chang-Geol, Hur, Jin, Chung, Hyunsoo, Park, Jun Chul, Jung, Da Hyun, Shin, Sung Kwan, Lee, Sang Kil, Lee, Yong Chan, Kim, Hye Ryun, Moon, Yong Wha, Kim, Joo Hang, Shim, Young Mog, Jewell, Susan S., Kim, Hyunki, Choi, Yoon-La, Cho, Byoung Chul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385871/ https://www.ncbi.nlm.nih.gov/pubmed/25537505 |
Ejemplares similares
-
PIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinoma
por: Kim, Hyo Song, et al.
Publicado: (2016) -
Phase II clinical and exploratory biomarker study of dacomitinib in recurrent and/or metastatic esophageal squamous cell carcinoma
por: Kim, Hyo Song, et al.
Publicado: (2015) -
High CD3 and ICOS and low TIM-3 expression predict favourable survival in resected oesophageal squamous cell carcinoma
por: Hong, Min Hee, et al.
Publicado: (2019) -
The feasibility and safety of radical esophagectomy in patients receiving neoadjuvant chemoradiotherapy with pembrolizumab for esophageal squamous cell carcinoma
por: Park, Seong Yong, et al.
Publicado: (2020) -
Dose-Response Relationship between Radiation Dose and Loco-regional Control in Patients with Stage II-III Esophageal Cancer Treated with Definitive Chemoradiotherapy
por: Kim, Hyun Ju, et al.
Publicado: (2017)